Investigation into the impact of the peptide repertoire of Human Leukocyte Antigen (HLA) class I molecules HLA-A*24:02 and HLA-B*57:01 on interactions with the inhibitory Killer cell Immunoglobulin-like Receptor (KIR) KIR3DL1.